LACOSAMIDE is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Breckenridge Pharmaceutical, Inc.. The primary component is Lacosamide.
Product ID | 51991-348_21d8300b-b6d1-4a99-ac67-7fa92c1cc809 |
NDC | 51991-348 |
Product Type | Human Prescription Drug |
Proprietary Name | LACOSAMIDE |
Generic Name | Lacosamide |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2022-03-18 |
Marketing Category | ANDA / |
Application Number | ANDA204921 |
Labeler Name | Breckenridge Pharmaceutical, Inc. |
Substance Name | LACOSAMIDE |
Active Ingredient Strength | 50 mg/1 |
Pharm Classes | Decreased Central Nervous System Disorganized Electrical Activity [PE] |
DEA Schedule | CV |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-03-18 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA204921 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2016-06-15 |
Marketing End Date | 2016-06-16 |
Marketing Category | ANDA |
Application Number | ANDA204921 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2016-06-15 |
Marketing End Date | 2016-06-16 |
NDC | Brand Name | Generic Name |
---|---|---|
0121-0992 | Lacosamide | Lacosamide |
0121-1984 | Lacosamide | Lacosamide |
0121-2976 | Lacosamide | Lacosamide |
0121-3968 | Lacosamide | Lacosamide |
63850-0055 | Lacosamide | Lacosamide |
63850-0053 | Lacosamide | Lacosamide |
63850-0054 | Lacosamide | Lacosamide |
63850-0056 | Lacosamide | Lacosamide |
65162-912 | Lacosamide | Lacosamide |
0131-1810 | Vimpat | lacosamide |
0131-2470 | Vimpat | lacosamide |
0131-2477 | Vimpat | lacosamide |
0131-2478 | Vimpat | lacosamide |
0131-2479 | Vimpat | lacosamide |